CNS and Behavioural Pharmacology PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download CNS and Behavioural Pharmacology PDF full book. Access full book title CNS and Behavioural Pharmacology by M. Airaksinen. Download full books in PDF and EPUB format.
Author: M. Airaksinen
Publisher: Elsevier
ISBN: 1483157784
Category : Medical
Languages : en
Pages : 354
Get Book
Book Description
CNS and Behavioural Pharmacology is the third volume of the proceedings of the Sixth International Congress of Pharmacology, organized by the Finnish Pharmacological Society and held in Helsinki, Finland, on July 20-25, 1975. Contributors focus on the findings concerning the central nervous system (CNS) and on the developments in behavioral pharmacology and related areas of research. This volume has 33 chapters divided into five sections. After discussing the application of psychopharmacology to the conservation of wild animals such as ungulates, this book turns its attention to alcohol dependence and the interactions between neurotransmitters and the hypothalamic releasing hormones. The reader is methodically introduced to the pharmacology of emotive behavior, with emphasis on drug effects in mental and emotional disorders as well as the action of psychotropic drugs on emotions, motivations, and social behavior of animals. The final section is devoted to the pharmacological aspects of the cerebrospinal fluid-transport system. This section covers topics such as the metabolism of biogenic amines in the human CNS; the importance of dopamine metabolism for the clinical effects and side effects of neuroleptics; and composite transport systems for organic acids and bases in choroid plexus. This book will be of interest to scientists representing all the major areas of pharmacology, including clinical pharmacology and toxicology, as well as to internists, psychiatrists, neurologists, and anesthesiologists.
Author: M. Airaksinen
Publisher: Elsevier
ISBN: 1483157784
Category : Medical
Languages : en
Pages : 354
Get Book
Book Description
CNS and Behavioural Pharmacology is the third volume of the proceedings of the Sixth International Congress of Pharmacology, organized by the Finnish Pharmacological Society and held in Helsinki, Finland, on July 20-25, 1975. Contributors focus on the findings concerning the central nervous system (CNS) and on the developments in behavioral pharmacology and related areas of research. This volume has 33 chapters divided into five sections. After discussing the application of psychopharmacology to the conservation of wild animals such as ungulates, this book turns its attention to alcohol dependence and the interactions between neurotransmitters and the hypothalamic releasing hormones. The reader is methodically introduced to the pharmacology of emotive behavior, with emphasis on drug effects in mental and emotional disorders as well as the action of psychotropic drugs on emotions, motivations, and social behavior of animals. The final section is devoted to the pharmacological aspects of the cerebrospinal fluid-transport system. This section covers topics such as the metabolism of biogenic amines in the human CNS; the importance of dopamine metabolism for the clinical effects and side effects of neuroleptics; and composite transport systems for organic acids and bases in choroid plexus. This book will be of interest to scientists representing all the major areas of pharmacology, including clinical pharmacology and toxicology, as well as to internists, psychiatrists, neurologists, and anesthesiologists.
Author: International Congress of Pharmacology
Publisher:
ISBN:
Category : Central nervous system
Languages : en
Pages : 0
Get Book
Book Description
Author: Nuno Sousa
Publisher: Frontiers Media SA
ISBN: 2889716228
Category : Science
Languages : en
Pages : 133
Get Book
Book Description
Author: C. Thomas Gualtieri
Publisher: Springer Science & Business Media
ISBN: 1461390362
Category : Medical
Languages : en
Pages : 361
Get Book
Book Description
Neuropsychiatry and Behavioral Pharmacology explores the neuropsychiatric consequences of congenital and acquired brain lesions and their appropriate pharmacologic treatment. The clinical problems addressed - practically, though always in a theoretical framework - are the severe behavioral disorders of children, of retarded people, of people with epilepsy, and of victims of traumatic brain injury. Topics examined include the neuropsychiatric and delayed neurobehavioral sequelae of traumatic brain injury, inadvertent drug effects, self-injurious behavior, Cornelia De Lange syndrome, autism, tardive dyskinesia, and childhood hyperactivity.
Author: Travis Thompson
Publisher: Psychology Press
ISBN: 1317784960
Category : Psychology
Languages : en
Pages : 224
Get Book
Book Description
This volume continues to document and summarize developments, trends, and emergent interdisciplinary research in behavioral psychopharmacology. For researchers and graduate students in psychopharmacology, behavioral pharmacology, toxicology, and the neurosciences. This seventh volume continues to document and summarize developments, trends, and emergent interdisciplinary research in behavioral psychopharmacology. For researchers and graduate students in psychopharmacology, behavioral pharmacology, toxicology, and the neurosciences. This is the latest volume in a series that continues to document and summarize developments, trends, and emergent interdisciplinary research in behavioral pharmacology, psychopharmacology, and the neurosciences. The chapters, written by authorities in their respective research areas, provide up-to-date examination and analysis of dominant evolving research areas. Designed as a resource text for professionals, as well as a supplementary text for upper level undergraduate and graduate students of behavioral pharmacology, psychopharmacology, psychobiology, and related fields, this book, like the others in the Advances in Behavioral Pharmacology Series, provides comprehensive coverage unavailable elsewhere.
Author: N. Krasnegor
Publisher: Routledge
ISBN: 131783819X
Category : Psychology
Languages : en
Pages : 325
Get Book
Book Description
First published in 1986. This monograph is based on a conference sponsored by the Human Learning and Behavior Branch of the National Institute of Child Health and Human Development, NIH. The meeting that was held at the Xerox Center in Leesburg, Virginia, in August 1983, brought together a group of leading researchers for the purpose of providing an overview of the emerging field of developmental behavioral pharmacology. More specifically, as is evidenced by the chapters in this volume, the intent was to put the field into historical perspective, render a working definition, and outline strategies and tactics for conducting behavioral pharmacological research in the developing organism.
Author: Norman A. Krasnegor
Publisher: Psychology Press
ISBN: 9780898596762
Category : Medical
Languages : en
Pages : 330
Get Book
Book Description
First Published in 1986. Routledge is an imprint of Taylor & Francis, an informa company.
Author: Bernard Weiss
Publisher: Springer Science & Business Media
ISBN: 1468426346
Category : Medical
Languages : en
Pages : 300
Get Book
Book Description
Author: T. Thompson
Publisher: Psychology Press
ISBN: 1317768086
Category : Psychology
Languages : en
Pages : 336
Get Book
Book Description
First published in 1987. Advances in Behavioral Pharmacology has broadened its scope in an attempt to provide a better understanding of behavioral actions of drugs and their applied implications. Each volume will be increasingly thematic and successive volumes will cover a wider range of issues. Some publications in this series, such as the present volume 6, Neurobehavioral Pharmacology, will primarily explore relations between neurochemistry and related areas of neurobiology and behavioral pharmacology.
Author: Robert A. McArthur
Publisher: Academic Press
ISBN: 0080920411
Category : Science
Languages : en
Pages : 1367
Get Book
Book Description
Animal and Translational Models for CNS Drug Discovery combines the experience of academic, clinical and pharmaceutical neuroscientists in a unique collaborative approach to provide a greater understanding of the relevance of animal models of neuropsychiatric disorders and their role as translational tools for the discovery of CNS drugs being developed for the treatment of these disorders. The focus of this three-volume series of essays is to present a consensual picture of the translational value of animal models from leading experts actively involved in the use of animal models for understanding fundamental neurobiology of CNS disorders and the application of this knowledge to CNS drug discovery, and clinical investigators involved in clinical trials, drug development and eventual registration of novel pharmaceuticals. Each volume of the Animal and Translational Models for CNS Drug Discovery series is dedicated to the development and use of animal models in key therapeutic areas in psychiatric, neurologic and reward deficit disorders. Each volume has introductory chapters expressing the view of the role and relevance of animal models for CNS drug discovery and development from the perspective of (a) academic basic neuroscientific research, (b) applied pharmaceutical drug discovery and development, and (c) issues of clinical trial design and regulatory agencies limitations. Each volume examines the rationale, use, robustness and limitations of animal models in relevant therapeutic areas and discusses the use of animal models for target identification and validation. The clinical relevance of animal models is discussed in terms of major limitations in cross-species comparisons, clinical trial design of drug candidates, and how clinical trial endpoints could be improved. The aim of this series of volumes on Animal and Translational Models for CNS Drug Discovery is to identify and provide common endpoints between species that can serve to inform both the clinic and the bench with the information needed to accelerate clinically-effective CNS drug discovery. - Provides clinical, academic, government and industry perspectives fostering integrated communication between principle participants at all stages of the drug discovery process - Critical evaluation of animal and translational models improving transition from drug discovery and clinical development - Emphasizes what results mean to the overall drug discovery process - Explores issues in clinical trial design and conductance in each therapeutic area - Each volume is available for purchase individually.
